Because A-Fib also greatly increases a person’s risk of stroke, these patients also are prescribed blood thinners like apixaban or rivaroxaban, researchers said. But the combination of diltiazem with ...

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases.

Evil Lives Here revisits the chilling case of Myrle Miller, the Pennsylvania woman convicted of poisoning husband John Nichols for financial gain, sentenced to life in 2023 and who died in prison in ...

Atrial fibrillation is one of the most common heart rhythm problems in the world. It causes the heart to beat irregularly and sometimes very fast, which can lead to symptoms such as palpitations, ...

Many people take medications every day to treat common health problems such as allergies, high blood pressure, or bladder issues. These medicines can help people feel better and manage their symptoms.

People, the pharmaceutical giants have spent billions of dollars in drug ads on television, in medical journals and in many newspapers, magazines, or media sources to convince you to use their ...

I’m 72 years old, and I have been prescribed azathioprine for rheumatoid arthritis (RA). I have only mild discomfort in my hands and wrist, which came on […] ...

CorMedix announces $128.6 million of net revenue for the fourth quarter of 2025, largely driven by continued utilization of DefenCath by its outpatient dialysis customers. DefenCath sales contributed ...

Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, ...

Q4 2025 Net Revenue of $128.6 million - Pro Forma Full Year 2025 Net Revenue of $401.3 million - Q4 2025 Net Income of $14.0 million; Adjusted EBITDA of $77.2 million - Conference Call Scheduled for ...